BIOMAT Database Logo BIOMAT Database Logo

Cytotoxicity of mitomycin C and carboquone combined with hyperthermia against hypoxic tumor cells in vitro. 1992

Y Sakaguchi, and S Kohnoe, and Y Emi, and Y Maehara, and T Kusumoto, and K Sugimachi
Cancer Center of Kyushu University Hospital, Department of Surgery II, Faculty of Medicine, Kyushu University, Fukuoka, Japan.

Enhancement of the cytotoxicity of mitomycin C (MMC) and carboquone (CQ) by hypoxia at elevated temperature was examined using the SDI test of mouse Sarcoma 180 and Ehrlich cells and clonogenic assay of HeLa cells. When Sarcoma 180 and Ehrlich cells were incubated at 43 degrees C for 2-10 h, the hyperthermic effect was enhanced by hypoxia. The succinate dehydrogenase activity of the cells was reduced by hyperthermia to a greater extent in the presence of hypoxia (O2:5%) than under conditions of aeration (O2:20%). When the cells were exposed to various concentrations of MMC and CQ, under hypoxia, activity of the drugs was enhanced compared to the findings under conditions of aeration. The enhancement was prominent in case of drugs and hyperthermia combined. Clonogenicity of hypoxic HeLa cells was also reduced to a greater extent with this combination than in case of aerated cells. We tentatively speculate that hyperthermo-chemotherapy using MMC and CQ has a potential to attack selectively hypoxic cells present in a solid tumor.

UI MeSH Term Description Entries
D006979 Hyperthermia, Induced Abnormally high temperature intentionally induced in living things regionally or whole body. It is most often induced by radiation (heat waves, infra-red), ultrasound, or drugs. Fever Therapy,Hyperthermia, Local,Hyperthermia, Therapeutic,Thermotherapy,Induced Hyperthermia,Therapeutic Hyperthermia,Therapy, Fever,Local Hyperthermia
D002225 Carbazilquinone An alkylating agent structurally similar to MITOMYCIN and found to be effective in the treatment of leukemia and various other neoplasms in mice. It causes leukemia and thrombocytopenia in almost all human patients. Carboquinone,Carboquone,Esquinon
D002286 Carcinoma, Ehrlich Tumor A transplantable, poorly differentiated malignant tumor which appeared originally as a spontaneous breast carcinoma in a mouse. It grows in both solid and ascitic forms. Ehrlich Ascites Tumor,Ascites Tumor, Ehrlich,Ehrlich Tumor Carcinoma,Tumor, Ehrlich Ascites
D003131 Combined Modality Therapy The treatment of a disease or condition by several different means simultaneously or sequentially. Chemoimmunotherapy, RADIOIMMUNOTHERAPY, chemoradiotherapy, cryochemotherapy, and SALVAGE THERAPY are seen most frequently, but their combinations with each other and surgery are also used. Multimodal Treatment,Therapy, Combined Modality,Combined Modality Therapies,Modality Therapies, Combined,Modality Therapy, Combined,Multimodal Treatments,Therapies, Combined Modality,Treatment, Multimodal,Treatments, Multimodal
D006367 HeLa Cells The first continuously cultured human malignant CELL LINE, derived from the cervical carcinoma of Henrietta Lacks. These cells are used for, among other things, VIRUS CULTIVATION and PRECLINICAL DRUG EVALUATION assays. Cell, HeLa,Cells, HeLa,HeLa Cell
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000332 Aerobiosis Life or metabolic reactions occurring in an environment containing oxygen. Aerobioses
D000693 Anaerobiosis The complete absence, or (loosely) the paucity, of gaseous or dissolved elemental oxygen in a given place or environment. (From Singleton & Sainsbury, Dictionary of Microbiology and Molecular Biology, 2d ed) Anaerobic Metabolism,Anaerobic Metabolisms,Anaerobioses,Metabolism, Anaerobic,Metabolisms, Anaerobic
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000971 Antineoplastic Combined Chemotherapy Protocols The use of two or more chemicals simultaneously or sequentially in the drug therapy of neoplasms. The drugs need not be in the same dosage form. Anticancer Drug Combinations,Antineoplastic Agents, Combined,Antineoplastic Chemotherapy Protocols,Antineoplastic Drug Combinations,Cancer Chemotherapy Protocols,Chemotherapy Protocols, Antineoplastic,Drug Combinations, Antineoplastic,Antineoplastic Combined Chemotherapy Regimens,Combined Antineoplastic Agents,Agent, Combined Antineoplastic,Agents, Combined Antineoplastic,Anticancer Drug Combination,Antineoplastic Agent, Combined,Antineoplastic Chemotherapy Protocol,Antineoplastic Drug Combination,Cancer Chemotherapy Protocol,Chemotherapy Protocol, Antineoplastic,Chemotherapy Protocol, Cancer,Chemotherapy Protocols, Cancer,Combinations, Antineoplastic Drug,Combined Antineoplastic Agent,Drug Combination, Anticancer,Drug Combination, Antineoplastic,Drug Combinations, Anticancer,Protocol, Antineoplastic Chemotherapy,Protocol, Cancer Chemotherapy,Protocols, Antineoplastic Chemotherapy,Protocols, Cancer Chemotherapy

Related Publications

Y Sakaguchi, and S Kohnoe, and Y Emi, and Y Maehara, and T Kusumoto, and K Sugimachi
Enhancement by hyperthermia of the in vitro cytotoxicity of mitomycin C toward hypoxic tumor cells.
March 1981, Cancer research,
Y Sakaguchi, and S Kohnoe, and Y Emi, and Y Maehara, and T Kusumoto, and K Sugimachi
Hypoxia and acidity increase the cytotoxicity of mitomycin C and carboquone to human tumor cells in vitro.
January 1991, Anticancer research,
Y Sakaguchi, and S Kohnoe, and Y Emi, and Y Maehara, and T Kusumoto, and K Sugimachi
Hypoxia enhances the lethality of mitomycin C and carboquone against human malignant tumor cells in vitro.
January 1989, European surgical research. Europaische chirurgische Forschung. Recherches chirurgicales europeennes,
Y Sakaguchi, and S Kohnoe, and Y Emi, and Y Maehara, and T Kusumoto, and K Sugimachi
Enhancement of mitomycin C cytotoxicity to hypoxic tumor cells by dicoumarol in vivo and in vitro.
January 1985, Cancer research,
Y Sakaguchi, and S Kohnoe, and Y Emi, and Y Maehara, and T Kusumoto, and K Sugimachi
Potentiation of the cytotoxicity of carboquone by flavone acetic acid combined with hyperthermia.
September 1997, Anti-cancer drugs,
Y Sakaguchi, and S Kohnoe, and Y Emi, and Y Maehara, and T Kusumoto, and K Sugimachi
Flavone acetic acid increases the cytotoxicity of mitomycin C when combined with hyperthermia.
January 1996, Cancer chemotherapy and pharmacology,
Y Sakaguchi, and S Kohnoe, and Y Emi, and Y Maehara, and T Kusumoto, and K Sugimachi
Hydralazine combined with hyperthermia enhances the effects of carboquone.
January 1994, Oncology,
Y Sakaguchi, and S Kohnoe, and Y Emi, and Y Maehara, and T Kusumoto, and K Sugimachi
Mechanisms of hypoxic and aerobic cytotoxicity of mitomycin C in Chinese hamster V79 cells.
December 1991, Cancer research,
Y Sakaguchi, and S Kohnoe, and Y Emi, and Y Maehara, and T Kusumoto, and K Sugimachi
In vitro activities of mitomycin C against growing and hypoxic dormant tubercle bacilli.
August 2001, Antimicrobial agents and chemotherapy,
Y Sakaguchi, and S Kohnoe, and Y Emi, and Y Maehara, and T Kusumoto, and K Sugimachi
Tumor tissue is more sensitive to mitomycin C, carboquone, and aclacinomycin A than is adjacent normal tissue in vitro.
January 1989, Journal of surgical oncology,
Copied contents to your clipboard!